Recent Posts
- Cycle Pharmaceuticals is pleased to announce that it has signed an agreement with Baylor Genetics
- Health Canada has approved an updated version of the NITISINONE TABLETS’ Product Monograph
- Cycle Pharmaceuticals and Catalent Partner to Develop Treatments for Rare Diseases using Zydis ODT Technology
- NITYR (nitisinone) Tablets for tyrosinaemia type 1 will be available with fully subsidised access on the Life Saving Drugs Program across Australia
- Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile
Archives
- No comments have been published yet.
Find us on Facebook
Archives
Recent Posts
- Cycle Pharmaceuticals is pleased to announce that it has signed an agreement with Baylor Genetics
- Health Canada has approved an updated version of the NITISINONE TABLETS’ Product Monograph
- Cycle Pharmaceuticals and Catalent Partner to Develop Treatments for Rare Diseases using Zydis ODT Technology
- NITYR (nitisinone) Tablets for tyrosinaemia type 1 will be available with fully subsidised access on the Life Saving Drugs Program across Australia
- Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile
Recent Tweets
-
@sebas_sir Send us an email to support@theme-fusion.com and include your information, we will check this for you
1 day ago -
Say hello to the Avada Landscaper demo. A great starting point to build a website for your springtime outdoor busin… twitter.com/i/web/status/1…
5 days ago -
Where do you find your web design inspiration when handling client work?
2 weeks ago
Recent Comments